References
1. Martinez-Perez O, Prats Rodriguez P, Muner Hernandez M, et al.The association between SARS-CoV-2 infection and preterm delivery: a
prospective study with a multivariable analysis. BMC Pregnancy and
Childbirth 2021; 21 : 273.
2. Vousden N, Bunch K, Morris E, et al. The incidence,
characteristics and outcomes of pregnant women hospitalized with
symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March
to September 2020: A national cohort study using the UK Obstetric
Surveillance System (UKOSS). PLOS ONE 2021; 16 :
e0251123.
3. Gale C, Quigley MA, Placzek A, et al. Characteristics and
outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective
national cohort study using active surveillance. The Lancet Child
& Adolescent Health 2021; 5 : 113-121.
4. Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2,
CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and
immune cells in health and in asthma, COPD, obesity, hypertension, and
COVID-19 risk factors. Allergy 2020; 75 : 2829-2845.
5. Monteil V, Kwon H, Prado P, et al. Inhibition of SARS-CoV-2
Infections in Engineered Human Tissues Using Clinical-Grade Soluble
Human ACE2. Cell 2020; 181 : 905-913.e907.
6. Duke-Cohan JS, Morimoto C, Rocker JA, Schlossman SF. A Novel Form of
Dipeptidylpeptidase IV Found in Human Serum: Isolation,
Characterization, and Comparison with T Lymphocyte Membrane
Dipeptidylpeptidase IV (CD26). Journal of Biological Chemistry1995; 270 : 14107-14114.
7. Blume C, Jackson CL, Spalluto CM, et al. A novel ACE2 isoform
is expressed in human respiratory epithelia and is upregulated in
response to interferons and RNA respiratory virus infection.Nature Genetics 2021; 53 : 205-214.
8. Tang W, Chang SB, Hemler ME. Links between CD147 function,
glycosylation, and caveolin-1. Molecular biology of the cell2004; 15 : 4043-4050.
9. Solun B, Shoenfeld Y. Inhibition of metalloproteinases in therapy for
severe lung injury due to COVID-19. Medicine in Drug Discovery2020; 7 : 100052.
10. Ueland T, Holter JC, Holten AR, et al. Distinct and early
increase in circulating MMP-9 in COVID-19 patients with respiratory
failure. The Journal of infection 2020; 81 : e41-e43.